Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression
- PMID: 27142736
- DOI: 10.1016/j.jnutbio.2016.01.011
Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression
Abstract
Fucoidan, a sulfated polysaccharide extracted from brown seaweeds, possesses many biological activities including anti-inflammatory and antioxidant activities. We aimed to investigate the protective effects of fucoidan on dyslipidemia and atherosclerosis in apolipoprotein E-deficient mice (ApoE(shl) mice) and to elucidate its molecular targets in the liver by using a transcriptomic approach. For 12weeks, ApoE(shl) mice were fed a high-fat diet (HFD) supplemented with either 1% or 5% fucoidan. Fucoidan supplementation significantly reduced tissue weight (liver and white adipose tissue), blood lipid, total cholesterol (TC), triglyceride (TG), non-high-density lipoprotein cholesterol (non-HDL-C) and glucose levels in HFD-fed ApoE(shl) mice but increased plasma lipoprotein lipase (LPL) activity and HDL-C levels. Fucoidan also reduced hepatic steatosis levels (liver size, TC and TG levels, and lipid peroxidation) and increased white adipose tissue LPL activity. DNA microarray analysis and quantitative reverse transcription-polymerase chain reaction demonstrated differential expression of genes encoding proteins involved in lipid metabolism, energy homeostasis and insulin sensitivity, by activating Ppara and inactivating Srebf1. Fucoidan supplementation markedly reduced the thickness of the lipid-rich plaque, lipid peroxidation and foaming macrophage accumulation in the aorta in HFD-fed ApoE(shl) mice. Thus, fucoidan supplementation appears to have anti-dyslipidemic and anti-atherosclerotic effects by inducing LPL activity and inhibiting the effects of inflammation and oxidative stress in HFD-fed ApoE(shl) mice.
Keywords: ApoE(shl) mice; Atherosclerosis; Dyslipidemia; Fucoidan; High-fat diet.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Fucoidan A2 from the Brown Seaweed Ascophyllum nodosum Lowers Lipid by Improving Reverse Cholesterol Transport in C57BL/6J Mice Fed a High-Fat Diet.J Agric Food Chem. 2019 May 22;67(20):5782-5791. doi: 10.1021/acs.jafc.9b01321. Epub 2019 May 13. J Agric Food Chem. 2019. PMID: 31055921
-
Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice.Nutrients. 2023 Jan 3;15(1):246. doi: 10.3390/nu15010246. Nutrients. 2023. PMID: 36615905 Free PMC article.
-
The fucoidan from the brown seaweed Ascophyllum nodosum ameliorates atherosclerosis in apolipoprotein E-deficient mice.Food Funct. 2019 Aug 1;10(8):5124-5139. doi: 10.1039/c9fo00619b. Epub 2019 Jul 31. Food Funct. 2019. PMID: 31364648
-
Fucoidan: Biological Activity in Liver Diseases.Am J Chin Med. 2020;48(7):1617-1632. doi: 10.1142/S0192415X20500809. Epub 2020 Nov 5. Am J Chin Med. 2020. PMID: 33148007 Review.
-
Potential Beneficial Actions of Fucoidan in Brain and Liver Injury, Disease, and Intoxication-Potential Implication of Sirtuins.Mar Drugs. 2020 May 5;18(5):242. doi: 10.3390/md18050242. Mar Drugs. 2020. PMID: 32380741 Free PMC article. Review.
Cited by
-
Fucoidan improving spinal cord injury recovery: Modulating microenvironment and promoting remyelination.CNS Neurosci Ther. 2024 Aug;30(8):e14903. doi: 10.1111/cns.14903. CNS Neurosci Ther. 2024. PMID: 39139089 Free PMC article.
-
The influence of processing technologies on the biological activity of carbohydrates in food.Food Chem X. 2024 Jun 23;23:101590. doi: 10.1016/j.fochx.2024.101590. eCollection 2024 Oct 30. Food Chem X. 2024. PMID: 39036475 Free PMC article.
-
Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.Mar Drugs. 2024 May 3;22(5):210. doi: 10.3390/md22050210. Mar Drugs. 2024. PMID: 38786601 Free PMC article. Review.
-
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation.Front Cardiovasc Med. 2024 Apr 18;11:1372055. doi: 10.3389/fcvm.2024.1372055. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38699583 Free PMC article. Review.
-
Laminaria japonica Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs.Cardiovasc Ther. 2024 Feb 12;2024:8649365. doi: 10.1155/2024/8649365. eCollection 2024. Cardiovasc Ther. 2024. PMID: 38375358 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous